Monday, September 10, 2018

Not Nice

Around 90,000 people in England have multiple sclerosis, which is a disease where the immune cells malfunction and attack the nervous system, causing mobility problems and gradual disability.

The National Institute for Health and Care Excellence (Nice), the body which rules on treatments the NHS should fund, ruled that it could not recommend ocrelizumab for primary progressive multiple sclerosis (PPMS) although the new drug can slow the disease and give up to seven additional years before they need a wheelchair. While ocrelizumab cannot cure, it could help delay the symptoms.

“You can’t imagine what it’s like to get a diagnosis of PPMS and be told there’s nothing for you,” says Holly Ford, 25, who was diagnosed with PPMS in March this year.

https://www.independent.co.uk/news/health/multiple-sclerosis-ms-wheelchair-progressive-nhs-drug-symptoms-nice-ocrelizumab-a8528071.html

No comments: